CREDIT AGREEMENT Dated as of May 24, 2022 among HALOZYME THERAPEUTICS, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, a Swing Line Lender and an L/C Issuer, and The Other Lenders and L/C Issuers Party Hereto BofA SECURITIES,...Credit Agreement • May 24th, 2022 • Halozyme Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This CREDIT AGREEMENT (“Agreement”) is entered into as of May 24, 2022, among HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), HALOZYME, INC., a California corporation, each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), each L/C Issuer (as hereinafter defined) from time to time party hereto and BANK OF AMERICA, N.A., as Administrative Agent and Swing Line Lender.
SECURITY AGREEMENTSecurity Agreement • May 24th, 2022 • Halozyme Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This SECURITY AGREEMENT, dated as of May 24, 2022 (this “Agreement”), is by and among HALOZYME THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), and certain of its Subsidiaries from time to time party hereto (collectively, together with the Borrower, the “Grantors”) and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”) for itself, the other lending institutions and L/C issuers (hereinafter, collectively, the “Lenders”) which are or may become parties to that certain Credit Agreement, dated as of the date hereof, by and among the Borrower, the Lenders party thereto and the Administrative Agent (as amended, supplemented, restated or otherwise modified and in effect from time to time, the “Credit Agreement”), and the other Secured Parties.
